AI Transparency Report
Lazarex Cancer Foundation demonstrates a commitment to its mission, with program expenses consistently forming the largest portion of its total spending. For example, in 2023, total expenses were $6,230,037, and program service expenses were $5,295,531, representing approximately 85% of total expenses. The organization has also maintained a strong balance sheet in previous years, with assets significantly exceeding liabilities, though the most recent filing shows a notable decrease in assets from $6,902,437 in 2022 to $4,149,538 in 2023, alongside an increase in liabilities from $1,833,202 to $1,573,884. This shift warrants closer examination to understand the underlying financial activities.
While the organization's program spending is commendable, a trend of expenses exceeding revenue has been observed in recent years. In 2023, expenses ($6,230,037) significantly outpaced revenue ($3,734,815), resulting in a deficit. Similar trends were seen in 2022 and 2021. This sustained operational deficit, if not addressed, could impact long-term financial stability. The organization's transparency is enhanced by its consistent filing of IRS Form 990s, which show no reported officer compensation, indicating that executive leadership is not drawing a salary from the organization, which is a positive sign for donor confidence.
Overall, Lazarex Cancer Foundation appears to be an organization dedicated to its mission, effectively channeling resources into programs. However, the recent financial deficits and the decrease in assets suggest a need for strategic financial planning to ensure sustainability. Donors should review the detailed financial statements to understand the nature of these deficits and the organization's plans to achieve financial equilibrium.